(Q36806657)

16 August 2017

1 reference

title

Is mild cognitive impairment a valid target of therapy (English)

1 reference

mild cognitive impairment

16 August 2017

main subject

1 reference

inferred from title

cognitive dysfunction

1 reference

2

Howard Chertkow

0 references

Kenneth Rockwood

series ordinal

1

object named as

Kenneth Rockwood

1 reference

16 August 2017

Howard H Feldman

3

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Canadian Journal of Neurological Sciences

16 August 2017

published in

1 reference

16 August 2017

volume

34 Suppl 1

1 reference

16 August 2017

page(s)

S90-6

1 reference

Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Perspectives on depression, mild cognitive impairment, and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild cognitive impairment: conceptual basis and current nosological status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Behavioral symptoms in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Cognitive frailty: Predementia syndrome and vascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Prevalence of mild cognitive impairment in 60- to 64-year-old community-dwelling individuals: The Personality and Total Health through Life 60+ Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Outcomes of incident mild cognitive impairment in relation to case definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Neuropathology of cognitively normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Challenges of epidemiological studies of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Misclassification is likely in the assessment of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

MRI and CSF studies in the early diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Validity of a novel computerized cognitive battery for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Five-Year Follow-up of Cognitive Impairment With No Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Subclassifications for mild cognitive impairment: prevalence and predictive validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Variations in case definition affect prevalence but not outcomes of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild cognitive impairment, amnestic type: an epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Epidemiology of gait disorders in community-residing older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild cognitive impairment and 10-year trajectories of disability in the Iowa Established Populations for Epidemiologic Studies of the Elderly cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Absence of cognitive impairment or decline in preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Current epidemiology of mild cognitive impairment and other predementia syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Conceptualization of mild cognitive impairment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Factors associated with inconsistent diagnosis of dementia between physicians and neuropsychologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Predicting cognitive decline in healthy older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Vascular risk factors, incidence of MCI, and rates of progression to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Impact of APOE in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild cognitive impairment can be detected by multiple assessments in a single day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Subcortical vascular disease and functional decline: a 6-year predictor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Is MCI really just early dementia? A systematic review of conversion studies.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Prevalence of mild cognitive impairment: a population-based study in elderly subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Five-Year Outcomes for Dementia Defined Solely by Neuropsychological Test Performance

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Current Epidemiology of Mild Cognitive Impairment and Other Predementia Syndromes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100005643

7 January 2021

10.1017/S0317167100005643

Identifiers

DOI

1 reference

release_npeu4nk7mrd3vahhc5fvci3a7y

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/npeu4nk7mrd3vahhc5fvci3a7y

24 November 2022

mapped directly with Wikidata item

1 reference